Clinical trials
Terminated Marijuana Abuse trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2019 | 2 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Canopy Growth Corporation | 1 |
| Dr. Laura Gaudet | 1 |
| The Epilepsy Research Program of the Ontario Brain Institute | 1 |
| University Health Network, Toronto | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Marijuana Abuse | 4 |
| Color Vision Defects | 1 |
| Drug Resistant Epilepsy | 1 |
| Epilepsy | 1 |
| Fetal Growth Retardation | 1 |
| Placenta Diseases | 1 |
| Seizures | 1 |
| Sleep Initiation and Maintenance Disorders | 1 |
| Substance-Related Disorders | 1 |
| Tics | 1 |
Trials
Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.